These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2406038)

  • 1. Biochemical markers as prognostic indices in breast cancer.
    Duffy MJ
    Clin Chem; 1990 Feb; 36(2):188-91. PubMed ID: 2406038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer.
    Isola J; Weitz S; Visakorpi T; Holli K; Shea R; Khabbaz N; Kallioniemi OP
    J Clin Oncol; 1993 Jan; 11(1):36-43. PubMed ID: 8093367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters.
    Buck A; Schirrmeister H; Kühn T; Shen C; Kalker T; Kotzerke J; Dankerl A; Glatting G; Reske S; Mattfeldt T
    Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1317-23. PubMed ID: 12271413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HER-2/neu oncogene protein and prognosis in breast cancer.
    Tandon AK; Clark GM; Chamness GC; Ullrich A; McGuire WL
    J Clin Oncol; 1989 Aug; 7(8):1120-8. PubMed ID: 2569032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.
    Gusterson BA; Gelber RD; Goldhirsch A; Price KN; Säve-Söderborgh J; Anbazhagan R; Styles J; Rudenstam CM; Golouh R; Reed R
    J Clin Oncol; 1992 Jul; 10(7):1049-56. PubMed ID: 1351538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between epidermal growth factor receptor status and various prognostic factors in human breast cancer.
    Toi M; Nakamura T; Mukaida H; Wada T; Osaki A; Yamada H; Toge T; Niimoto M; Hattori T
    Cancer; 1990 May; 65(9):1980-4. PubMed ID: 2372767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Internal mammary nodal status is a more reliable prognostic factor than DNA ploidy and c-erb B-2 expression in patients with breast cancer.
    Noguchi M; Koyasaki N; Ohta N; Kitagawa H; Earashi M; Thomas M; Miyazaki I; Mizukami Y
    Arch Surg; 1993 Feb; 128(2):242-6. PubMed ID: 8094282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [C-erbB-2, EGF receptor, p53 and PCNA. The prognostic significance of recent tumor markers for lymph node negative breast cancer].
    Schönborn I; Minguillon C; Lichtenegger W; Zschiesche W; Spitzer E
    Geburtshilfe Frauenheilkd; 1995 Oct; 55(10):566-71. PubMed ID: 8543129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme-linked immunosorbent assay of c-erbB-2 oncoprotein in breast cancer.
    Nugent A; McDermott E; Duffy K; O'Higgins N; Fennelly JJ; Duffy MJ
    Clin Chem; 1992 Aug; 38(8 Pt 1):1471-4. PubMed ID: 1353709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective evaluation of prognostic factors in operable breast cancer.
    Hawkins RA; Tesdale AL; Killen ME; Jack WJ; Chetty U; Dixon JM; Hulme MJ; Prescott RJ; McIntyre MA; Miller WR
    Br J Cancer; 1996 Nov; 74(9):1469-78. PubMed ID: 8912547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ki67 index in breast cancer: correlation with other prognostic markers and potential in pakistani patients.
    Haroon S; Hashmi AA; Khurshid A; Kanpurwala MA; Mujtuba S; Malik B; Faridi N
    Asian Pac J Cancer Prev; 2013; 14(7):4353-8. PubMed ID: 23992002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic contribution of the HER-2 oncogene overexpression to the Nottingham Prognostic Index in breast cancer.
    Suen D; Chow LW
    Biomed Pharmacother; 2006 Jul; 60(6):293-7. PubMed ID: 16828252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic and predictive value of c-erbB-2 overexpression in primary breast cancer, alone and in combination with other prognostic markers.
    Sjögren S; Inganäs M; Lindgren A; Holmberg L; Bergh J
    J Clin Oncol; 1998 Feb; 16(2):462-9. PubMed ID: 9469329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of expression of breast epithelial mucin detected by monoclonal antibody BrE-3 in breast-cancer prognosis.
    Ceriani RL; Chan CM; Baratta FS; Ozzello L; DeRosa CM; Habif DV
    Int J Cancer; 1992 May; 51(3):343-54. PubMed ID: 1592525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 as an independent prognostic marker in lymph node-negative breast cancer patients.
    Silvestrini R; Benini E; Daidone MG; Veneroni S; Boracchi P; Cappelletti V; Di Fronzo G; Veronesi U
    J Natl Cancer Inst; 1993 Jun; 85(12):965-70. PubMed ID: 8496982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients.
    Pinto AE; André S; Soares J
    J Clin Pathol; 1999 Aug; 52(8):604-11. PubMed ID: 10645231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of Bcl-2 in invasive mammary carcinomas: a comparative clinicopathologic study between "triple-negative" and non-"triple-negative" tumors.
    Tawfik K; Kimler BF; Davis MK; Fan F; Tawfik O
    Hum Pathol; 2012 Jan; 43(1):23-30. PubMed ID: 21777944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological significance and prognostic value of CD133 expression in triple-negative breast carcinoma.
    Zhao P; Lu Y; Jiang X; Li X
    Cancer Sci; 2011 May; 102(5):1107-11. PubMed ID: 21276138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer.
    Wright C; Angus B; Nicholson S; Sainsbury JR; Cairns J; Gullick WJ; Kelly P; Harris AL; Horne CH
    Cancer Res; 1989 Apr; 49(8):2087-90. PubMed ID: 2564806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cathepsin D levels in primary breast cancers: relationship with epidermal growth factor receptor, oestrogen receptor and axillary nodal status.
    Sacks NP; Smith K; Norman AP; Greenall M; LeJeune S; Harris AL
    Eur J Cancer; 1993; 29A(3):426-8. PubMed ID: 8398346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.